САМАРҚАНД ВИЛОЯТИДА ГЕМОДИАЛИЗ ХИЗМАТИНИНГ ҲОЛАТИ ВА ГЕМОДИАЛИЗ ОЛАЁТГАН БЕМОРЛАРДА ЯШАБ ҚОЛИШ ҲАМДА ЎЛИМ КЎРСАТКИЧЛАРИНИНГ ТАҲЛИЛИ
##article.subject##:
соғлиқни сақлаш тизими, гемдиализ, сурункали буйрак касаллиги##article.abstract##
Мақолада Самарқанд вилоятида сўнги беш йилдаги гемодиализ хизматининг ҳолати ва шунингдек сурункали буйрак касаллиги мавжуд буйрак ўрин босувчи терапияси ўтказилаётган беморларнинг сони, уларнинг яшовчанлиги ва ўлим кўрсатгичлари келтирилган.
Библиографические ссылки
Bello, A. K. et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ 367, l5873 (2019).
Benghanem G.M., Elseviers M., Zamd M., et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid ‘over’- and ‘under’-diagnosis of CKD // Kidney Int. - 2016. - Vol. 89. - Р. 1363–1371.
Fraser S.D.S., Roderick P.J., Casey M., Taal M.W., Yuen H.M., Nutbeam D. Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review. Nephrology Dialysis Transplantation, 2013, vol. 28, no. 1, pp. 129–137. DOI: 10.1093/ndt/gfs371.
Goodkin, D. A. et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J. Am. Soc. Nephrol. 14, 3270–3277 (2003).
Herrera-Añazco, P., Benites-Zapata, V., Hernandez, A. V., Mezones-Holguin, E. & Silveira- Chau, M. Mortality in patients with chronic kidney disease undergoing hemodialysis in a public hospital of Peru. J. Bras. Nefrol. 37, 192–197 (2015).
Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16, 573–585 (2020).
Jack K.C. Ng., Li P.K.-T. Chronic kidney disease epidemic: How do we deal with it? Nephrology, vol. 23, no. 4, pp. 116–120. 2018. https://doi.org/10.1111/nep.13464.
Jardine, T., Wong, E., Steenkamp, R., Caskey, F. J. & Davids, M. R. Survival of South African patients on renal replacement therapy. Clin. Kidney J. 13, 782–790 (2020).
KDIGO Clinical Practice Guideline for Glomerulonephritis // Kidney International Supplements. – 2012. - Vol. 2. - Р. 259–274.
Khazaei, S. et al. Survival rate and predictors of mortality among hemodialysis patients in West of Iran, 1996–2015. Int. J. Prev. Med. 9, 113 (2018).
Kidney Disease: Improving Global Outcomes (KDIGO)& CKD-MBD Work Group. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. Suppl. https://doi.org/10.1038/ki.2009.188 (2009).
Levey, A. S. et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 97, 1117–1129 (2020).
Liu, F. X., Rutherford, P., Smoyer-Tomic, K., Prichard, S.& Laplante, S. A global overview of renal registries: a systematic review. BMC Nephrol. 16, 31 (2015).
Mathur R., Dreyer G., Yaqoob M.M., Hull S.A. Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study. BMJ Open, 2018, vol. 27, no. 8 (3), pp. e020145. DOI:10.1136/bmjopen-2017-020145.
Msaad, R. et al. Predictors of mortality in hemodialysis patients. Pan Afr. Med. J. 33, 61 (2019).
Nordio, M. et al. Survival in patients treated by long-term dialysis compared with the general population. Am. J. Kidney Dis. 59, 819–828 (2012).
Parving H.H., Brenner B.M., McMurray J.J.V, et al, for the ALTITUDE Investigators. Cardiorenal end points in a trial of aliskiren for type 2 diabetes // N Engl J Med. 2012. Vol.367. Р. 2204–2213.
Pecoits-Filho, R. et al. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. Kidney Int. Suppl. 10, e3–e9 (2020).
United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020); ANZDATA Registry. 43rd Report, Chapter 4: Haemodialysis. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA, Adelaide, Australia, 2020.).
Stalpers, Lucas J.A.; Kaplan, Edward L. (May 4, 2018). "Edward L. Kaplan and the Kaplan- Meyer survival curve." Bulletin of the BSHM: Journal of the British Society for the History of Mathematics. 33 (2): 109–135. doi:10.1080/17498430.2018.1450055. S2CID 125941631.
